180 related articles for article (PubMed ID: 37442993)
1. Development of a novel drug information provision system for Kampo medicine using natural language processing technology.
Maeda-Minami A; Yoshino T; Yumoto T; Sato K; Sagara A; Inaba K; Kominato H; Kimura T; Takishita T; Watanabe G; Nakamura T; Mano Y; Horiba Y; Watanabe K; Kamei J
BMC Med Inform Decis Mak; 2023 Jul; 23(1):119. PubMed ID: 37442993
[TBL] [Abstract][Full Text] [Related]
2. The Integration of Traditional Medicine with Conventional Biomedicine: A Narrative Review of the Japanese Perspective.
Yoshino T; Kashio A; Terasawa Y; Hachiki M; Yoshinaga R; Arita R
J Integr Complement Med; 2023; 29(6-7):372-379. PubMed ID: 36961400
[No Abstract] [Full Text] [Related]
3. [Standardization of Crude Drugs for the Japanese Pharmacopoeia].
Hakamatsuka T
Yakugaku Zasshi; 2020; 140(6):783-788. PubMed ID: 32475928
[TBL] [Abstract][Full Text] [Related]
4. [Development of an Informative System for Consumers and Pharmacists Aimed at the Proper Use of Kampo OTCs].
Takano-Ohmuro H; Nakajima Y; Saito M; Yuda Y
Yakugaku Zasshi; 2016; 136(2):273-9. PubMed ID: 26831805
[TBL] [Abstract][Full Text] [Related]
5. Development of Kampoļ¼traditional Japanese medicineļ¼e-learning program: evaluation of the flipped classroom for medical students.
Ito A; Watanabe K; Fukuzawa Y; Mitani K; Fujimoto S; Matsuda T; Sugiyama K; Kitamura K; Ban N
Med Educ Online; 2021 Dec; 26(1):1938504. PubMed ID: 34134610
[TBL] [Abstract][Full Text] [Related]
6. Predicting Japanese Kampo formulas by analyzing database of medical records: a preliminary observational study.
Yoshino T; Katayama K; Horiba Y; Munakata K; Yamaguchi R; Imoto S; Miyano S; Mima H; Watanabe K
BMC Med Inform Decis Mak; 2016 Sep; 16(1):118. PubMed ID: 27619018
[TBL] [Abstract][Full Text] [Related]
7. Patient safety incident reports related to traditional Japanese Kampo medicines: medication errors and adverse drug events in a university hospital for a ten-year period.
Shimada Y; Fujimoto M; Nogami T; Watari H; Kitahara H; Misawa H; Kimbara Y
BMC Complement Altern Med; 2017 Dec; 17(1):547. PubMed ID: 29268743
[TBL] [Abstract][Full Text] [Related]
8. [Kampo Medicine in the New Model Core Curriculum of Pharmaceutical Education].
Kobayashi Y
Yakugaku Zasshi; 2016; 136(3):423-32. PubMed ID: 26935081
[TBL] [Abstract][Full Text] [Related]
9. Cheminformatics modeling of the correlation between Bupleurum Root-formula medicines and Excess and Deficiency pattern in the diagnostic criteria of Sho in Kampo (traditional Japanese medicine) by non-targeted direct infusion mass spectrometry with machine learning.
Okada T; Namiki T; Tohge T; Kanaya S
J Nat Med; 2022 Jan; 76(1):306-313. PubMed ID: 34661849
[TBL] [Abstract][Full Text] [Related]
10. SemBioNLQA: A semantic biomedical question answering system for retrieving exact and ideal answers to natural language questions.
Sarrouti M; Ouatik El Alaoui S
Artif Intell Med; 2020 Jan; 102():101767. PubMed ID: 31980104
[TBL] [Abstract][Full Text] [Related]
11. Regulation of traditional herbal medicinal products in Japan.
Maegawa H; Nakamura T; Saito K
J Ethnopharmacol; 2014 Dec; 158 Pt B():511-5. PubMed ID: 25043783
[TBL] [Abstract][Full Text] [Related]
12. [What does "pharmacognosy" mean for pharmacists?].
Kawazoe K
Yakugaku Zasshi; 2011 Mar; 131(3):401-5. PubMed ID: 21372536
[TBL] [Abstract][Full Text] [Related]
13. [Marketing Approval of Ethical Kampo Medicines].
Hakamatsuka T
Yakugaku Zasshi; 2017; 137(2):163-165. PubMed ID: 28154326
[TBL] [Abstract][Full Text] [Related]
14. [Approach to Teaching Kampo Medicine at Kyoto Pharmaceutical University].
Matsuda H
Yakugaku Zasshi; 2016; 136(3):405-9. PubMed ID: 26935078
[TBL] [Abstract][Full Text] [Related]
15. [Biologically Active Constituents of Natural Medicines -A Mixture Can Do More].
Kiuchi F
Yakugaku Zasshi; 2022; 142(6):629-639. PubMed ID: 35650083
[TBL] [Abstract][Full Text] [Related]
16. Usage and attitudes of physicians in Japan concerning traditional Japanese medicine (kampo medicine): a descriptive evaluation of a representative questionnaire-based survey.
Moschik EC; Mercado C; Yoshino T; Matsuura K; Watanabe K
Evid Based Complement Alternat Med; 2012; 2012():139818. PubMed ID: 22319543
[TBL] [Abstract][Full Text] [Related]
17. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
[TBL] [Abstract][Full Text] [Related]
18. [Introduction of "clinical pharmacognosy"--integration between pharmacognosy and clinical pharmacy].
Makino T
Yakugaku Zasshi; 2011 Mar; 131(3):375-82. PubMed ID: 21372533
[TBL] [Abstract][Full Text] [Related]
19. The actual conditions of traditional Japanese Kampo education in all the pharmacy schools in Japan: a questionnaire survey after the enforcement of the new national 2015 core curriculum.
Nakada Y; Arai M
BMC Complement Altern Med; 2018 Nov; 18(1):297. PubMed ID: 30409153
[TBL] [Abstract][Full Text] [Related]
20. Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines.
Motoo Y; Arai I; Hyodo I; Tsutani K
Complement Ther Med; 2009 Jun; 17(3):147-54. PubMed ID: 19398068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
